Table 2.
Univariate and multivariable adjustment of HOMA-IR as predictor of clinical outcome
| Univariate model | Multivariable model | |||
|---|---|---|---|---|
| HR (95 % CI) | p value | HR (95 % CI) | p value | |
| Age | 1.05 (1.03–1.08) | <0.001 | 1.04 (1.01–1.07) | 0.007 |
| Known CAD | 3.27 (2.10–5.10) | <0.001 | 1.87 (1.15–3.05) | 0.012 |
| Gender | 3.10 (1.92–5.01) | <0.001 | 1.92 (1.11–3.35) | 0.020 |
| HOMA-IR above median | 2.72 (1.70–4.46) | <0.001 | 1.88 (1.09–3.26) | 0.023 |
| HDL | 0.38 (0.19–0.75) | 0.005 | 0.82 (0.41–1.63) | 0.570 |
| Systolic blood pressure | 1.01 (1.00–1.02) | 0.036 | 1.00 (0.99–1.01) | 0.693 |
| Body mass index | 1.05 (0.99–1.12) | 0.120 | 1.00 (0.92–1.08) | 0.915 |
Survival analyses on the whole study population of non-diabetic patients with suspected myocardial ischemia. Data are presented with hazard ratio and 95 % CI, (n = 365)
CI confidence interval, HDL high density lipoprotein cholesterol, HR hazard ratio Known CAD previously known coronary artery disease